HYCC1

HYCC1 (FAM126A/hyccin) is an essential subunit of the plasma membrane phosphatidylinositol 4-kinase machinery that controls PtdIns(4)P synthesis required for nervous system myelination (PMID:26571211, PMID:16951682). It is an intrinsic component of the PI4KIIIα complex together with TTC7 and EFR3, where it forms an all-α-helical heterodimer with TTC7 through a large protein-protein interface whose conserved surface mediates binding to PI4KIIIα (PMID:26571211). By directly stabilizing this assembly, HYCC1 sustains plasma membrane PtdIns(4)P levels; its loss destabilizes the complex and reduces PtdIns(4)P in patient fibroblasts and mouse brain (PMID:26571211). Biallelic loss-of-function mutations in HYCC1 cause an autosomal recessive leukodystrophy characterized by hypomyelination of the central and peripheral nervous system with congenital cataract (PMID:16951682), consistent with neuronal expression that peaks during early postnatal myelinogenesis (PMID:22461884). The disease-associated L53P missense variant misfolds and aggregates in the endoplasmic reticulum, activating unfolded protein response kinases (PMID:24417797). Beyond its myelination role, HYCC1 (DRCTNNB1A) is transcriptionally repressed downstream of beta-catenin signaling (PMID:10910037), and an interaction with ENO1 that activates PI3K/AKT signaling has been documented in pancreatic cancer cells (PMID:35513377).

1. 2000 Medium

   Established the gene as a transcriptional target downstream of oncogenic signaling, the first functional context before any mechanistic role was known.

   Evidence Adenoviral APC transfer with RT-PCR/Northern blot readout in colon cancer cells and primary colorectal tumors

   PMID:10910037

   Open questions at the time

   • Does not identify the gene's molecular function
   • Direct vs. indirect transcriptional regulation by beta-catenin/Tcf-Lef not resolved
2. 2006 High

   Linked the gene to human disease, defining hyccin as an essential protein whose loss causes hypomyelination with congenital cataract.

   Evidence Genetic mapping and mutation identification across five affected families with protein characterization

   PMID:16951682

   Open questions at the time

   • Molecular mechanism connecting loss to hypomyelination not established
   • Cellular function of the protein unknown at this stage
3. 2012 Medium

   Resolved which cells express hyccin during myelination, pointing to a neuronal rather than glial site of action.

   Evidence LacZ reporter knock-in mouse, cell-type-marker immunofluorescence, and organotypic Schwann cell/DRG cultures

   PMID:22461884

   Open questions at the time

   • Proposed neuron-to-glia signaling role not mechanistically demonstrated
   • Single lab
4. 2013 Medium

   Defined how a specific disease allele acts at the protein level, showing L53P causes ER aggregation and UPR activation.

   Evidence Subcellular localization by immunofluorescence in transfected cells and UPR kinase activity assays

   PMID:24417797

   Open questions at the time

   • Whether UPR activation drives myelination defects in vivo unknown
   • Effect on PI4KIIIα complex not tested in this study
5. 2015 High

   Defined the core molecular function: hyccin is an intrinsic subunit of the plasma membrane PI4KIIIα lipid kinase complex that stabilizes it and is required for PtdIns(4)P synthesis, mechanistically explaining disease.

   Evidence Co-IP, phosphoinositide measurements in patient fibroblasts, mouse brain fractionation, and a co-crystal structure of the FAM126A-TTC7 heterodimer with PI4KIIIα-binding surface mapped

   PMID:26571211

   Open questions at the time

   • How reduced PtdIns(4)P specifically impairs myelination not delineated
   • Structure of the full PI4KIIIα-TTC7-EFR3 holocomplex not resolved here
6. 2022 Medium

   Identified a non-myelination function in cancer, with a direct ENO1 interaction activating PI3K/AKT to drive tumor cell behavior.

   Evidence Reciprocal Co-IP, co-localization, and ENO1 knockdown rescue in vitro and in vivo

   PMID:35513377

   Open questions at the time

   • Relationship between ENO1 binding and the PI4KIIIα complex role unclear
   • Single lab; mechanism of PI3K/AKT activation downstream of the interaction not detailed

• How loss of plasma membrane PtdIns(4)P is translated into the specific failure of CNS/PNS myelination, and how this reconciles with hyccin's neuronal expression and signaling-context functions, remains unresolved.
• No mechanistic link from PtdIns(4)P deficit to myelin biogenesis
• Cell-type-specific requirement for the PI4KIIIα complex in myelination untested